The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation.
Islet amyloid polypeptide (IAPP), also known as amylin, is responsible for amyloid formation in type 2 diabetes. The formation of islet amyloid is believed to contribute to the pathology of the disease by killing beta-cells, and it may also contribute to islet transplant failure. The design of inhibitors of amyloid formation is an active area of research, but comparatively little attention has been paid to inhibitors of IAPP in contrast to the large body of work on beta-amyloid, and most small-molecule inhibitors of IAPP amyloid are generally effective only when used at a significant molar excess. Here we show that the simple sulfonated triphenyl methane derivative acid fuchsin, 3-(1-(4-amino-3-methyl-5-sulfonatophenyl)-1-(4-amino-3-sulfonatophenyl) methylene) cyclohexa-1,4-dienesulfonic acid, is a potent inhibitor of in vitro amyloid formation by IAPP at substoichiometric levels and protects cultured rat INS-1 cells against the toxic effects of human IAPP. Fluorescence-detected thioflavin-T binding assays, light-scattering, circular dichroism, two-dimensional IR, and transmission electron microscopy measurements confirm that the compound prevents amyloid fibril formation. Ionic-strength-dependent studies show that the effects are mediated in part by electrostatic interactions. Experiments in which the compound is added at different time points during the lag phase after amyloid formation has commenced reveal that it arrests amyloid formation by trapping intermediate species. The compound is less effective against the beta-amyloid peptide, indicating specificity in its ability to inhibit amyloid formation by IAPP. The work reported here provides a new structural class of IAPP amyloid inhibitors and demonstrates the power of two-dimensional infrared spectroscopy for characterizing amyloid inhibitor interactions.
Meng
Fanling
F
Department of Chemistry, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA.
Abedini
Andisheh
A
Plesner
Annette
A
Middleton
Chris T
CT
Potter
Kathryn J
KJ
Zanni
Martin T
MT
Verchere
C Bruce
CB
Raleigh
Daniel P
DP
D000682:Amyloid / Q000037:antagonists & inhibitors* / Q000633:toxicity / Q000648:ultrastructure; D000818:Animals; D001557:Benzenesulfonates / Q000378:metabolism*; D002460:Cell Line; D002470:Cell Survival; D006801:Humans; D058228:Islet Amyloid Polypeptide; D046529:Microscopy, Electron, Transmission; D015394:Molecular Structure; D011485:Protein Binding; D051381:Rats; D055672:Static Electricity
D000682:Amyloid; D001557:Benzenesulfonates; D058228:Islet Amyloid Polypeptide; C086337:acid fuchsin
Endocrinology. 1994 Oct;135(4):1651-60
7925129
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7720-5
18499799
Diabetologia. 1989 May;32(5):271-81
2526768
Endocr Rev. 1994 Apr;15(2):163-201
8026387
Lancet. 1987 Aug 1;2(8553):231-4
2441214
Exp Gerontol. 2003 Apr;38(4):347-51
12670620
Acc Chem Res. 2008 Oct;41(10):1309-18
18937396
J Phys Chem B. 2009 Feb 26;113(8):2498-505
19182939
J Biol Chem. 1997 Dec 12;272(50):31617-24
9395501
Biochem Biophys Res Commun. 1986 Nov 14;140(3):827-31
3535798
J Am Chem Soc. 2007 Sep 19;129(37):11300-1
17722920
Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14197-202
17502604
J Am Chem Soc. 2008 May 28;130(21):6698-9
18459774
Curr Alzheimer Res. 2007 Sep;4(4):473-8
17908052
Anal Biochem. 2006 Apr 15;351(2):181-6
16406209
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6646-51
9192619
N Engl J Med. 2008 Aug 28;359(9):977-9
18753660
Biochemistry. 2008 Jun 3;47(22):6016-24
18457428
Angew Chem Int Ed Engl. 2008;47(25):4679-82
18470855
Angew Chem Int Ed Engl. 2008;47(37):7114-8
18688904
Opt Express. 2006 Dec 25;14(26):13120-30
19532209
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3881-5
3035556
Neuropsychopharmacology. 2009 Jan;34(1):126-41
18800065
Org Lett. 2005 Feb 17;7(4):693-6
15704927
Nature. 1994 Apr 21;368(6473):756-60
8152488
J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
15292279
Neurobiol Aging. 2007 Apr;28(4):537-47
16675063
N Engl J Med. 2007 Jun 7;356(23):2413-5
17554124
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4305-10
20160085
J Biol Chem. 2004 Apr 23;279(17):17490-9
14752113
Chem Biol Drug Des. 2006 Jan;67(1):27-37
16492146
Diabetes. 2004 Jan;53(1):141-8
14693708
Nat Chem Biol. 2008 Mar;4(3):197-9
18223646
Diabetes. 2001 Mar;50(3):534-9
11246872
Diabetologia. 2009 Jan;52(1):145-53
19002432
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2046-51
16467158
Biochemistry. 2005 Dec 13;44(49):16284-91
16331989
Opt Lett. 2006 Mar 15;31(6):838-40
16544641
N Engl J Med. 2007 Jun 7;356(23):2349-60
17554116
Virchows Arch A Pathol Anat Histopathol. 1992;421(4):339-44
1413495
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6614-9
19346479
Diabetes Res. 1988 Dec;9(4):151-9
3073901
Phys Chem Chem Phys. 2009 Feb 7;11(5):748-61
19290321
Nat Med. 1995 Feb;1(2):143-8
7585011
Nat Cell Biol. 2004 Nov;6(11):1054-61
15516999
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18349-54
19015532
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17751-6
19815514
Diabetes. 2008 Nov;57(11):2899-904
18971437
Diabetes. 1998 Apr;47(4):612-20
9568695
Diabetes. 1999 Feb;48(2):241-53
10334297
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8628-32
3317417
J Mol Biol. 2001 May 4;308(3):515-25
11327784
J Biol Chem. 1990 Mar 15;265(8):4173-6
2407732
Crit Rev Clin Lab Sci. 1994;31(4):325-54
7888076
Ups J Med Sci. 2003;108(3):193-203
15000457
Biochemistry. 2004 Nov 16;43(45):14454-62
15533050
Diabetes. 2003 Jan;52(1):102-10
12502499
J Phys Chem B. 2009 Nov 26;113(47):15679-91
19883093